SCHEMBL23930932

SCHEMBL23930932

CCCCn1cncc1C(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.51
CYP11B2 P19099 1/20 0.51
MAPK1 P28482 1/20 0.42
TLR8 Q9NR97 2/20 0.40
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
GRM2 Q14416 1/20 0.37
HTR7 P34969 1/20 0.37
HTR6 P50406 1/20 0.37
QPCT Q16769 4/20 0.37
POLB P06746 1/20 0.36
CNR1 P21554 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
KDM4E B2RXH2 2/20 0.36
GLA P06280 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5726023 0.95 CYP11B1 (0.50) CYP11B1CYP11B2MAPK1TLR8CA12
SCHEMBL8799103 0.94 CYP11B1 (0.49) CYP11B1CYP11B2MAPK1TLR8GRM2
SCHEMBL7424605 0.83 CYP11B1 (0.59) CYP11B1CYP11B2MAPK1CA12CA1
SCHEMBL6336700 0.83 CYP11B1 (0.41) CYP11B1CYP11B2MAPK1TLR8GRM2
SCHEMBL23930976 0.82 ALDH1A1 (0.40) CYP11B1CYP11B2CA12CA1CA2
SCHEMBL15202361 0.82 GABRA1 (0.47) CYP11B1CYP11B2CNR1ALDH1A1CYP1A2
SCHEMBL27264726 0.80 CYP11B1 (0.45) CYP11B1CYP11B2MAPK1CA1CA2
SCHEMBL31203889 0.79 CYP11B1 (0.49) CYP11B1CYP11B2MAPK1GRM2HTR7
SCHEMBL18185717 0.79 CYP11B1 (0.55) CYP11B1CYP11B2MAPK1GRM2HTR7
SCHEMBL31332952 0.79 CYP11B1 (0.55) CYP11B1CYP11B2MAPK1GRM2HTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021215545-A1 ANTICANCER COMBINATION THERAPY WITH N-(1-ACRYLOYL-AZETIDIN-3-YL)-2-((1H-INDAZOL-3-YL)AMINO)METHYL)-1H-IMIDAZOLE-5-CARBOXAMIDE INHIBITOR OF KRAS-G12C TAIHO PHARMACEUTICAL CO., LTD. (JP) 2021-10-28 WO disclosed